Overview

Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
To assess the optimal sequence of the palliative chemotherapy regimen (DP --> FOLFIRI vs FOLFIRI --> DP) in metastatic gastric cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Cisplatin
Docetaxel
Irinotecan